Board of Directors
Executive Directors
Mr. Xie Cheng (Chairman) (appointed on 22 October 2025 and Chairman of the board on 30 January 2026)
Mr. Xie joined our Group and was appointed as executive Director on 22 October 2025. Mr. Xie has over 5 years of experience in corporate management and corporate strategic development. Mr. Xie is currently the president of 華夏水務(北京)有限公司 Hua Xia Water (Beijing) Co. Ltd.* and the Chief Capital and Operating Officer of 貴州烤局餐飲連鎖有限公司 Guizhou Kaoju Catering Chain Co. Ltd.*. Mr. Xie obtained a graduation certificate from the Law School of Peking University in 2023.
Ms. Cai Ying (Chief Executive Officer)
Ms. Cai joined our Group and was appointed as executive Director on 8 January 2025 and Chief Executive Officer on 30 January 2026. Ms. Cai has over 20 years’ experience in financial management.
Ms. Cai was an independent non-executive director of Jiading International Group Holdings Limited (formerly known as Farnova Group Holdings Limited, stock code: 8153), a company listed on the GEM of the Stock Exchange, since September 2022 and redesignated as an executive director from February 2023 to July 2023. Since April 2020, she is a supervisor of 智合新天(北京)傳媒廣告股份有限公司 (New Sky Union (Beijing) Media and Advertising Company Limited*), the shares of which was formerly listed on the National Equities Exchange and Quotations of China.
*For identification purpose only
Mr. Garlos Lee (Southeast Asia General Manager)
Mr Lee co-founded our Group in May 2010 and was appointed as our general manager since April 2014 and appointed as executive Director on 18 August 2017. He is responsible for the overall management of our Group looking after all operations including sales, marketing, client services, human resources and finance of our Group. Since 15 February 2017, he become responsible for our Group’s business operations in the Southeast Asia region. Mr. Garlos Lee has over 10 years of working experience in the marketing and advertising industry.
Mr. Zhang Yu (appointed on 30 January 2026)
Mr. Zhang joined our Group and was appointed as executive director on 30 January 2026. Mr. Zhang is an entrepreneur and has over ten years of experience in corporate development and management.
Mr. Zhang graduated from the Department of Chemistry of Yunnan University in 1992. Mr. Zhang is the chairman of 三銀信息技術有限公司 Sanyin Information Technology Co., Ltd.*, a company engaging in the development of internet ecosystem in the People’s Republic of China (the ‘‘PRC’’) and 小聖生命科技(海南)有限公 司 Xiaosheng Life Science & Technology (Hainan) Co., Ltd.*, a company engaging in the development of health industry ecosystem in the PRC.
Mr. Fu Tao (appointed on 21 July 2025)
Mr. Fu joined our Group and was appointed as executive Director on 21 July 2025. He has over 15 years of experience in corporate management, investment banking and corporate finance.
Mr. Fu served as the principal staff member of International Cooperation Center of National Development and Reform Commission (國家發展和改革委員會國際合作中心), the director of legal compliance and risk management division of Happy Life Insurance Co., Ltd, an assistant director of the real estate finance division of Ping An Bank Co., Ltd, a president of asset management division of Tianhong Innovative Asset Management Co., Ltd (天弘創新資產管理有限公司), a chief risk officer of China One (Beijing) Asset Management Co., Ltd. (金榜(北京)基金管理有限公司). Prior to joining the Company, he was a director in the China investment banking division of GF Holdings (Hong Kong) Corporation Limited and a responsible officer for Type 1 and Type 6 regulated activities (dealing with securities and advising on corporate finance respectively) under the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) ("SFO").
*For identification purpose only
Independent Non-Executive Directors
Mr. Kwan Chi Hong
Mr Kwan was appointed as our independent non-executive Director on 7 March 2018. He is responsible for supervising, providing independent advice to our Board, serving as chairman of nomination committee, and member of audit committee for our Group.
Mr. Kwan was appointed as an independent non-executive director of BExcellent Group Holdings Limited (the shares of which are listed on the Main Board of the Stock Exchange, stock code: 1775) and China Brilliant Global Limited (formerly known as Prosten Health Holdings Limited) (the shares of which are listed on GEM of the Stock Exchange, stock code: 8026) on 17 November 2017 and 12 February 2018 respectively. Mr. Kwan was also appointed as a director of Bamboos Health Care Holdings Limited (“Bamboos Health Care”) (the shares of which were listed on GEM, stock code: 8216, and subsequently, were listed on the Main Board of the Stock Exchange, stock code: 2293) on 23 November 2012 and redesignated as an executive director on 28 March 2014, responsible for monitoring and evaluating the business, strategic planning and major decision making. Mr. Kwan has resigned as an executive director of Bamboos Health Care on 5 January 2019 and resigned as an independent non-executive director of China Brilliant Global Limited on 12 November 2021.
Mr. Kwan became an independent non-executive director of Janco Holdings Limited (the shares of which are listed on GEM of the Stock Exchange, stock code: 8035) on 7 May 2021 and resigned on 15 October 2022.
Mr. Ho Ho Tung, Armen
Mr Ho was appointed as our independent non-executive Director on 7 March 2018. He is responsible for supervising, providing independent advice to our Board, serving as chairman of the audit committee and member of each of remuneration and nomination committee for our Group.
Mr. Ho has been the chief financial officer and company secretary of Tianyun International Holdings Limited (the shares of which are listed on the Main Board of the Stock Exchange, stock code: 6836) between February 2015 and May 2024. Mr. Ho has been an independent non-executive director of Diwang Industrial Holdings Limited (formerly known as Sunlight Technology Holdings Limited) (stock code: 1950) since the company’s listing in March 2020. Mr. Ho has been appointed as an independent director of Reitar Logtech Holdings Limited, a company listed on NASDAQ (Nasdaq: RITR), since June 2024.
Mr. Yiu Chun Wing (formerly known as Mr. Yiu Ka Wai) (appointed on 19 December 2025)
Mr. Yiu Chun Wing joined our Group and was appointed as an independent non-executive Director on 19 December 2025. He is responsible for supervising, providing independent advice to our Board, servicing as chairman of remuneration committee and member of audit committee for our Group.
Mr. Yiu is a member of the Hong Kong Institute of Certified Public Accountants and graduated from the Hong Kong University of Science and Technology with a Bachelor of business administration in accounting. Mr. Yiu is currently the Financial Controller and Company Secretary at China Infrastructure & Logistics Group Ltd, a company listed on the Main Board of the Stock Exchange (Stock Code: 1719). Mr. Yiu is the independent non-executive director of SoftMedx Healthcare Limited (Stock Code: 0648), a company listed on the Main Board of the Stock Exchange since December 2022. Mr. Yiu had 21 years of experience in the areas of audit, financial management and reporting and corporate governance and years of audit experience at a number of accounting firms in Hong Kong.
Ms. Meng Mei (appointed on 21 August 2025)
Ms. Meng was appointed as our independent non-executive Director on 21 August 2025. She is responsible for supervising, providing independent advice to our Board, serving as member of audit committee, member of remuneration committee, and member of nomination committee for our Group.
Ms. Meng has over 5 years of experience in the health and beauty industry and has been engaged in corporate management, talent development and marketing. From September 2019 to June 2023, Ms. Meng has taken up various senior management positions in Beijing Dai Mu Bio-Technology Limited (北京黛木生物科技有限公司), Guangzhou Dai Mu BioTechnology Limited (廣州黛木生物科技有限公司) and Guangzhou Dai Mu Pharmaceutical Technology Limited (廣州黛木超凡藥業科技有限公司). Since September 2020, Ms. Meng served as the chairman of Zhong Ding International Health Limited (中鼎國際健康有限公司) and was primarily responsible for the management and operation of the company. Ms. Meng completed tertiary course in fashion design at Art and Design college of Qiqihar University in 2011 and a short course in corporate governance and compliance at School of Journalism & Communication of Peking University.
*For identification purpose only